Mutational analysis of SMN gene in patients with spinal muscular atrophy and the correlation between mutation and the severity of clinical manifestations

Мутационный анализ SMN генау пациентов со спинальной мышечной атрофией и связь между мутацией и тяжестью клинических проявлений
Almagul Nagimtaeeva 1, Dina Zhanataeva 1, Bakytgul Kamalieva 1, Gulshara Abildinova 1
More Detail
1 National research center for maternal and child health of the Corporate Fund “UMC”, Astana, Kazakhstan
J CLIN MED KAZ, Volume 3, Issue 45 special issue, pp. 18-21. https://doi.org/10.23950/1812-2892-JCMK-00484
OPEN ACCESS 2824 Views 2583 Downloads
Download Full Text (PDF)

ABSTRACT

Objective: studying of mutations in the SMN1, SMN2 and NAIP genes in the diagnosis of spinal muscular atrophy and determining the correlation between the mutation and the severity of clinical manifestations.
Methods: 82 children with suspicion of spinal muscular atrophy were examined. Genomic DNA was isolated from the whole blood of patients using the Wizard®Genomic DNA Purifcation kit (Promega). Further diagnostics was carried out using the MLPA method on a 96-capillary automatic analyzer 3730xl DNA Analyzer. The results were processed using the software Coffalyser DB.v.130.
Results: A homozygous deletion of the exons 7-8 of the SMN1 gene was observed in all SMA patients of this study. At the same time, the deletion of the exon 7 of the SMN1 gene and an increase in the number of copies of SMN2, 1 (2%) and 2 (4%), respectively, were found among patients with type II and III type of SMA. In the analysis of deletions of exons 7-8 of the SMN1 gene, the SMN1 gene was completely deleted in 15 (29%), 2 (4%) and 1 (2%) SMA I, II and III patients. The study revealed that the NAIP gene was deleted in 8 patients (19.2%) with type I CMA and in two patients (4%) with SMA type II. Also, in a single patient with a type II SMA, deletions of the exon 8 of the SMN1 1 gene (2%) was found.
Conclusion: the MLPA method allows not only to confrm the diagnosis of spinal amyotrophy, but also to specify the type of spinal amyotrophy depending on the detected changes in the SMN1, SMN2 and NAIP genes. The clinical diagnosis of SMA is mainly based on the identifcation of homozygous deletions of the 7th and 8th exons of the SMN1 gene. Deletion of the NAIP gene and an increase in the number of copies of SMN2 are considered to assess the clinical phenotype of CMA patients.
Keywords: spinal muscular atrophy, genes SMN1, SMN2 and NAIP, MLPA - method, deletion

CITATION

Nagimtaeeva A, Zhanataeva D, Kamalieva B, Abildinova G. Mutational analysis of SMN gene in patients with spinal muscular atrophy and the correlation between mutation and the severity of clinical manifestations. Journal of Clinical Medicine of Kazakhstan. 2017;3(45 special issue):18-21. https://doi.org/10.23950/1812-2892-JCMK-00484

REFERENCES

  • Darras B.T. Spinal muscular atrophies. Pediatr. 2015; 62(3):743–766.
  • Faravelli I., Nizzardo M., Comi G.P., Corti S. Spinal muscular atrophy – recent therapeutic advances for an old challenge. Neurol. 2015; 11(6):351–359.
  • Monani U.R., Lorson C.L., Parsons D.W. et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet. 1999; 8(7):1177–1183.
  • Darras B.T. Non-5q spinal muscular atrophies: the alphanumeric soup thickens. Neurology. 2011; 77(4): 312–314.
  • Maretina M.A., Kiselev A.B., Zheleznjakova G.Ju., Egorova A.A., Vaharlovskij V.G., Tishhenko L.I., Baranov B.C. Determination of the number of copies of the SMN2 gene in patients with spinal muscular atrophy of the North-West region of Russia. Medical Genetics. 2012; (4):25-28.
  • Watihayati. MS, Zabidi-Hussin AM, ТаngТH, Matsuo M, Nishio H, Zilfalil BA. Deletion analyses of SMN1 and NAIP genes in Malaysian spinal muscular atrophy patients. PediatrInt. 2007; 49(1):11–4.
  • Omrani O, Bonyadi M, Barzgar M. Molecular analyses of the SMN and NAIP genes in Iranian spinal muscular atrophy patients. Pediatr. 2009; 51(2):193–6.
  • Romanish M.T, Nakamura H., Lai C.B., et al. PloS ONE. 2009; 4(6):e5761.
  • Ogino S., Wilson R.B. Spinal muscular atrophy: molecular genetics and diagnostics. Expert Rev. Mol. Diagn. 2004; 4(1):15-29.
  • Maretina М., Kiselev А., Zheleznyakova G., Egorova А., Baranov V. Study of positive modifiers of spinal muscular atrophy severity in Russian patients. Nürnberg, Germany. 2012; 20: 334-335.
  • Ogino S., Gao S., Leonard D.G., Paessler М., Wilson R.B. Inverse correlation between SMN1 and SMN2 copy numbers: Evidence for gene conversion from SMN2 to SMN1. Eur. J. Hum. Genet. 2003; 11:275-277.
  • Zabnenkova V.V., Dadali E.L., Poljakov A.V. Analysis of the carriage of deletions in the SMN gene responsible for the occurrence of type I-IV spinal muscular atrophy. Medical Genetics. 2012. 11(1):3-9.
  • Scarciolla O., Stuppia L., De Angelis M.V., Murru S., Palka C., Giuliani R., et all. Spinal muscular atrophy genotyping by gene dosage using multiple ligation-de- pendent probe amplification. Neurogenetics. 2006; 7(4):239-76.